Alpine Immune Sciences (ALPN) Stock Forecast, Price Target & Predictions
ALPN Stock Forecast
Alpine Immune Sciences stock forecast is as follows: an average price target of $55.00 (represents a -15.35% downside from ALPN’s last price of $64.97) and a rating consensus of 'Hold', based on 5 wall street analysts offering a 1-year stock forecast.
ALPN Price Target
ALPN Analyst Ratings
Hold
Alpine Immune Sciences Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Apr 11, 2024 | Robert Driscoll | Wedbush | $65.00 | $47.04 | 38.18% | 0.05% |
Apr 11, 2024 | Michael Ulz | Morgan Stanley | $65.00 | $47.04 | 38.18% | 0.05% |
Apr 09, 2024 | Vamil Divan | Guggenheim | $55.00 | $38.53 | 42.75% | -15.35% |
Mar 20, 2024 | Andy Chen | Wolfe Research | $46.00 | $40.23 | 14.34% | -29.20% |
Mar 19, 2024 | Justin Kim | Oppenheimer | $44.00 | $39.95 | 10.14% | -32.28% |
10
Alpine Immune Sciences Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | - | 5 |
Avg Price Target | - | - | $55.00 |
Last Closing Price | $64.97 | $64.97 | $64.97 |
Upside/Downside | -100.00% | -100.00% | -15.35% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
May 16, 2024 | RBC Capital | Underperform | Underperform | Hold |
May 16, 2024 | Wedbush | Market Perform | Market Perform | Hold |
Apr 15, 2024 | Cowen & Co. | - | Hold | Downgrade |
Apr 12, 2024 | Leerink Partners | - | Market Perform | Downgrade |
Apr 09, 2024 | Wedbush | Buy | Buy | Hold |
Apr 09, 2024 | RBC Capital | Underperform | Underperform | Hold |
Apr 09, 2024 | Guggenheim | - | Buy | Initialise |
Mar 19, 2024 | Wedbush | Buy | Buy | Hold |
Jan 26, 2024 | Wedbush | Buy | Buy | Hold |
Jan 26, 2024 | RBC Capital | Underperform | Underperform | Hold |
10
Alpine Immune Sciences Financial Forecast
Alpine Immune Sciences Revenue Forecast
Quarter
Dec 25 | Oct 25 | Jul 25 | Mar 25 | Dec 24 | Oct 24 | Jul 24 | Mar 24 | Dec 23 | Oct 23 | Jul 23 | Mar 23 | Dec 22 | Oct 22 | Jul 22 | Mar 22 | Dec 21 | Oct 21 | Jul 21 | Mar 21 | Dec 20 | Oct 20 | Jul 20 | Mar 20 | Dec 19 | Oct 19 | Jul 19 | Mar 19 | Mar 18 | Mar 17 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | $30.85M | - | - | $9.39M | $2.78M | - | - | $13.63M | $4.53M | - | - | $3.20M | $5.64M | - | - | $1.09M | $884.00K | - | - | - | $315.00K | - |
Avg Forecast | $19.87M | $17.13M | $14.77M | $12.73M | $4.72M | $3.00M | $2.99M | $2.22M | $9.10M | $7.25M | $7.08M | $6.88M | $10.96M | $18.68M | $10.04M | $16.26M | $13.97M | $21.19M | $7.77M | $6.67M | $3.10M | $5.10M | $2.13M | $376.67K | $183.33K | $250.00K | $83.33K | $113.00K | $328.42K | $616.67K |
High Forecast | $19.87M | $17.13M | $14.77M | $12.73M | $4.72M | $3.00M | $5.43M | $2.22M | $14.58M | $7.25M | $7.08M | $6.88M | $10.96M | $18.68M | $10.04M | $16.26M | $13.97M | $21.19M | $7.77M | $6.67M | $3.10M | $5.10M | $2.13M | $376.67K | $183.33K | $250.00K | $83.33K | $113.00K | $394.10K | $740.00K |
Low Forecast | $19.87M | $17.13M | $14.77M | $12.73M | $4.72M | $3.00M | $1.63M | $2.22M | $2.61M | $7.25M | $7.08M | $6.88M | $10.96M | $18.68M | $10.04M | $16.26M | $13.97M | $21.19M | $7.77M | $6.67M | $3.10M | $5.10M | $2.13M | $376.67K | $183.33K | $250.00K | $83.33K | $113.00K | $262.74K | $493.33K |
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 5 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 10 | 10 | 10 | 10 | 9 | 9 | 9 | 9 | 20 | 7 |
Surprise % | - | - | - | - | - | - | - | - | 3.39% | - | - | 1.36% | 0.25% | - | - | 0.84% | 0.32% | - | - | 0.48% | 1.82% | - | - | 2.90% | 4.82% | - | - | - | 0.96% | - |
Forecast
Alpine Immune Sciences EBITDA Forecast
Quarter
Dec 25 | Oct 25 | Jul 25 | Mar 25 | Dec 24 | Oct 24 | Jul 24 | Mar 24 | Dec 23 | Oct 23 | Jul 23 | Mar 23 | Dec 22 | Oct 22 | Jul 22 | Mar 22 | Dec 21 | Oct 21 | Jul 21 | Mar 21 | Dec 20 | Oct 20 | Jul 20 | Mar 20 | Dec 19 | Oct 19 | Jul 19 | Mar 19 | Mar 18 | Mar 17 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 5 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 10 | 10 | 10 | 10 | 9 | 9 | 9 | 9 | 20 | 7 |
EBITDA | - | - | - | - | - | - | - | - | $1.55M | - | - | $-13.20M | $-18.23M | - | - | $-7.22M | $-16.75M | - | - | $-10.26M | $-5.97M | - | - | $-5.28M | $-6.57M | - | - | $-12.01M | $-5.20M | $-8.86M |
Avg Forecast | $-18.84M | $-16.24M | $-14.00M | $-12.07M | $-4.48M | $-2.85M | $-2.83M | $-4.32M | $-8.63M | $-6.88M | $-6.71M | $-4.62M | $-7.94M | $-17.72M | $-9.53M | $-4.94M | $-13.25M | $-20.09M | $-7.37M | $-7.70M | $-2.94M | $-4.83M | $-2.02M | $-7.19M | $-173.87K | $-237.09K | $-79.03K | $-12.21M | $-5.33M | $-4.39M |
High Forecast | $-18.84M | $-16.24M | $-14.00M | $-12.07M | $-4.48M | $-2.85M | $-1.55M | $-3.46M | $-2.48M | $-6.88M | $-6.71M | $-3.70M | $-6.35M | $-17.72M | $-9.53M | $-3.95M | $-13.25M | $-20.09M | $-7.37M | $-6.16M | $-2.94M | $-4.83M | $-2.02M | $-5.75M | $-173.87K | $-237.09K | $-79.03K | $-9.77M | $-4.27M | $-3.51M |
Low Forecast | $-18.84M | $-16.24M | $-14.00M | $-12.07M | $-4.48M | $-2.85M | $-5.15M | $-5.18M | $-13.83M | $-6.88M | $-6.71M | $-5.54M | $-9.53M | $-17.72M | $-9.53M | $-5.93M | $-13.25M | $-20.09M | $-7.37M | $-9.23M | $-2.94M | $-4.83M | $-2.02M | $-8.62M | $-173.87K | $-237.09K | $-79.03K | $-14.65M | $-6.40M | $-5.26M |
Surprise % | - | - | - | - | - | - | - | - | -0.18% | - | - | 2.86% | 2.30% | - | - | 1.46% | 1.26% | - | - | 1.33% | 2.03% | - | - | 0.73% | 37.81% | - | - | 0.98% | 0.98% | 2.02% |
Forecast
Alpine Immune Sciences Net Income Forecast
Quarter
Dec 25 | Oct 25 | Jul 25 | Mar 25 | Dec 24 | Oct 24 | Jul 24 | Mar 24 | Dec 23 | Oct 23 | Jul 23 | Mar 23 | Dec 22 | Oct 22 | Jul 22 | Mar 22 | Dec 21 | Oct 21 | Jul 21 | Mar 21 | Dec 20 | Oct 20 | Jul 20 | Mar 20 | Dec 19 | Oct 19 | Jul 19 | Mar 19 | Mar 18 | Mar 17 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 5 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 10 | 10 | 10 | 10 | 9 | 9 | 9 | 9 | 20 | 7 |
Net Income | - | - | - | - | - | - | - | - | $5.96M | - | - | $-11.01M | $-18.86M | - | - | $-7.53M | $-15.17M | - | - | $-10.64M | $-6.34M | - | - | $-5.53M | $-6.14M | - | - | $-12.38M | $-5.31M | $-8.92M |
Avg Forecast | $-30.26M | $-29.60M | $-30.89M | $-30.04M | $-25.34M | $-28.08M | $-26.25M | $-4.50M | $-21.13M | $-21.41M | $-24.01M | $-4.82M | $-7.87M | $-5.76M | $-24.01M | $-5.15M | $-18.25M | $1.28M | $-21.98M | $-7.98M | $-19.96M | $-14.89M | $-14.94M | $-7.53M | $-37.46M | $-43.54M | $-43.38M | $-12.20M | $-5.44M | $-7.13M |
High Forecast | $-30.26M | $-29.60M | $-30.89M | $-30.04M | $-25.34M | $-28.08M | $-18.75M | $-3.60M | $-16.51M | $-21.41M | $-24.01M | $-3.85M | $-6.29M | $-5.76M | $-24.01M | $-4.12M | $-18.25M | $1.28M | $-21.98M | $-6.39M | $-19.96M | $-14.89M | $-14.94M | $-6.03M | $-37.46M | $-43.54M | $-43.38M | $-9.76M | $-4.35M | $-5.71M |
Low Forecast | $-30.26M | $-29.60M | $-30.89M | $-30.04M | $-25.34M | $-28.08M | $-31.25M | $-5.40M | $-25.75M | $-21.41M | $-24.01M | $-5.78M | $-9.44M | $-5.76M | $-24.01M | $-6.18M | $-18.25M | $1.28M | $-21.98M | $-9.58M | $-19.96M | $-14.89M | $-14.94M | $-9.04M | $-37.46M | $-43.54M | $-43.38M | $-14.64M | $-6.53M | $-8.56M |
Surprise % | - | - | - | - | - | - | - | - | -0.28% | - | - | 2.29% | 2.40% | - | - | 1.46% | 0.83% | - | - | 1.33% | 0.32% | - | - | 0.73% | 0.16% | - | - | 1.01% | 0.98% | 1.25% |
Forecast
Alpine Immune Sciences SG&A Forecast
Quarter
Dec 25 | Oct 25 | Jul 25 | Mar 25 | Dec 24 | Oct 24 | Jul 24 | Mar 24 | Dec 23 | Oct 23 | Jul 23 | Mar 23 | Dec 22 | Oct 22 | Jul 22 | Mar 22 | Dec 21 | Oct 21 | Jul 21 | Mar 21 | Dec 20 | Oct 20 | Jul 20 | Mar 20 | Dec 19 | Oct 19 | Jul 19 | Mar 19 | Mar 18 | Mar 17 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 5 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 10 | 10 | 10 | 10 | 9 | 9 | 9 | 9 | 20 | 7 |
SG&A | - | - | - | - | - | - | - | - | $6.37M | - | - | $5.40M | $4.39M | - | - | $4.78M | $4.54M | - | - | $3.26M | $3.05M | - | - | $1.78M | $2.10M | - | - | $2.35M | $2.11M | $2.78M |
Avg Forecast | $32.60M | $28.10M | $24.23M | $20.89M | $7.75M | $4.93M | $4.90M | $3.64M | $14.94M | $11.90M | $11.62M | $3.05M | $2.21M | $30.66M | $16.48M | $3.27M | $22.92M | $34.77M | $12.75M | $2.44M | $5.09M | $8.36M | $3.50M | $618.07K | $300.83K | $410.23K | $136.74K | $185.42K | $538.91K | $1.01M |
High Forecast | $32.60M | $28.10M | $24.23M | $20.89M | $7.75M | $4.93M | $8.92M | $3.64M | $23.93M | $11.90M | $11.62M | $3.67M | $2.65M | $30.66M | $16.48M | $3.92M | $22.92M | $34.77M | $12.75M | $2.93M | $5.09M | $8.36M | $3.50M | $618.07K | $300.83K | $410.23K | $136.74K | $185.42K | $646.69K | $1.21M |
Low Forecast | $32.60M | $28.10M | $24.23M | $20.89M | $7.75M | $4.93M | $2.68M | $3.64M | $4.29M | $11.90M | $11.62M | $2.44M | $1.77M | $30.66M | $16.48M | $2.61M | $22.92M | $34.77M | $12.75M | $1.95M | $5.09M | $8.36M | $3.50M | $618.07K | $300.83K | $410.23K | $136.74K | $185.42K | $431.12K | $809.51K |
Surprise % | - | - | - | - | - | - | - | - | 0.43% | - | - | 1.77% | 1.98% | - | - | 1.46% | 0.20% | - | - | 1.33% | 0.60% | - | - | 2.88% | 6.99% | - | - | 12.65% | 3.91% | 2.75% |
Forecast
Alpine Immune Sciences EPS Forecast
Quarter
Dec 25 | Oct 25 | Jul 25 | Mar 25 | Dec 24 | Oct 24 | Jul 24 | Mar 24 | Dec 23 | Oct 23 | Jul 23 | Mar 23 | Dec 22 | Oct 22 | Jul 22 | Mar 22 | Dec 21 | Oct 21 | Jul 21 | Mar 21 | Dec 20 | Oct 20 | Jul 20 | Mar 20 | Dec 19 | Oct 19 | Jul 19 | Mar 19 | Mar 18 | Mar 17 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 5 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 10 | 10 | 10 | 10 | 9 | 9 | 9 | 9 | 20 | 7 |
EPS | - | - | - | - | - | - | - | - | $0.15 | - | - | $-0.23 | $-0.41 | - | - | $-0.25 | $-0.52 | - | - | $-0.45 | $-0.27 | - | - | $-0.30 | $-0.33 | - | - | $-0.70 | $-0.38 | $-2.28 |
Avg Forecast | $-0.47 | $-0.46 | $-0.48 | $-0.47 | $-0.40 | $-0.44 | $-0.41 | $-0.43 | $-0.33 | $-0.33 | $-0.38 | $-0.37 | $-0.26 | $-0.09 | $-0.38 | $-0.17 | $-0.28 | $0.02 | $-0.34 | $-0.36 | $-0.31 | $-0.23 | $-0.23 | $-0.47 | $-0.58 | $-0.68 | $-0.68 | $-0.69 | $-0.40 | $-1.52 |
High Forecast | $-0.47 | $-0.46 | $-0.48 | $-0.47 | $-0.40 | $-0.44 | $-0.29 | $-0.43 | $-0.26 | $-0.33 | $-0.38 | $-0.37 | $-0.26 | $-0.09 | $-0.38 | $-0.17 | $-0.28 | $0.02 | $-0.34 | $-0.36 | $-0.31 | $-0.23 | $-0.23 | $-0.47 | $-0.58 | $-0.68 | $-0.68 | $-0.69 | $-0.32 | $-1.22 |
Low Forecast | $-0.47 | $-0.46 | $-0.48 | $-0.47 | $-0.40 | $-0.44 | $-0.49 | $-0.43 | $-0.40 | $-0.33 | $-0.38 | $-0.37 | $-0.26 | $-0.09 | $-0.38 | $-0.17 | $-0.28 | $0.02 | $-0.34 | $-0.36 | $-0.31 | $-0.23 | $-0.23 | $-0.47 | $-0.58 | $-0.68 | $-0.68 | $-0.69 | $-0.48 | $-1.82 |
Surprise % | - | - | - | - | - | - | - | - | -0.45% | - | - | 0.62% | 1.59% | - | - | 1.49% | 1.82% | - | - | 1.26% | 0.87% | - | - | 0.64% | 0.56% | - | - | 1.01% | 0.95% | 1.50% |
Forecast
Alpine Immune Sciences Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
ANEB | Anebulo Pharmaceuticals | $1.55 | $6.00 | 287.10% | Buy |
ACRV | Acrivon Therapeutics | $7.93 | $22.00 | 177.43% | Buy |
ABOS | Acumen Pharmaceuticals | $2.53 | $7.00 | 176.68% | Buy |
DAWN | Day One Biopharmaceuticals | $14.85 | $38.80 | 161.28% | Buy |
ANAB | AnaptysBio | $20.75 | $52.00 | 150.60% | Buy |
MLYS | Mineralys Therapeutics | $12.45 | $30.00 | 140.96% | Buy |
BCYC | Bicycle Therapeutics | $23.22 | $54.40 | 134.28% | Buy |
STOK | Stoke Therapeutics | $13.90 | $30.60 | 120.14% | Buy |
ADAG | Adagene | $2.37 | $5.00 | 110.97% | Buy |
TERN | Terns Pharmaceuticals | $6.78 | $14.25 | 110.18% | Buy |
IGMS | IGM Biosciences | $11.15 | $20.33 | 82.33% | Buy |
MLTX | MoonLake Immunotherapeutics | $51.06 | $79.33 | 55.37% | Buy |
AMLX | Amylyx Pharmaceuticals | $5.68 | $5.33 | -6.16% | Buy |
ALPN | Alpine Immune Sciences | $64.97 | $55.00 | -15.35% | Hold |